Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hormones and Bone Tissue01:17

Hormones and Bone Tissue

2.6K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.6K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
Bone Remodeling01:40

Bone Remodeling

38.2K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acid-Tolerant Photosensitizer: Photodynamic Inactivation of Porphyromonas gingivalis by 2',4',5',7'-Tetraiodofluorescein.

Pathogens (Basel, Switzerland)·2026
Same author

Exploring mechanisms of scar-free skin wound healing in adult zebrafish in comparison to mouse.

PLoS genetics·2026
Same author

Second interim analysis of the post-authorisation safety study (PASS) of burosumab in paediatric patients with X-linked hypophosphataemia.

European journal of endocrinology·2026
Same author

Intraoperative and postoperative evaluation of temporomandibular joint disc repositioning and suturing via anteriorly based or posteriorly based approaches to the neurovascular bundle: a retrospective single-center cohort study.

Head & face medicine·2026
Same author

Pharmacological Activation of NRF2 by Omaveloxolone Upregulates NRF2-Target Proteins in SMA Type I Human Fibroblasts.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same author

Prediction of Superheated Steam Temperature in Thermal Power Plants Based on the iTransformer Model.

Sensors (Basel, Switzerland)·2026

Related Experiment Video

Updated: Jun 13, 2025

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
08:42

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

4.4K

Functional Insights in PLS3-Mediated Osteogenic Regulation.

Wenchao Zhong1,2,3,4, Janine Neugebauer5,6, Janak L Pathak4

  • 1Department of Human Genetics, Amsterdam UMC Location Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.

Cells
|September 14, 2024
PubMed
Summary

Plastin-3 (PLS3) deficiency causes bone fragility. While other actin proteins partially compensate, PLS3

Keywords:
actin-bundling proteinosteogenic differentiationosteoporosisplastin-3transcriptome

More Related Videos

Isolation of Mesenchymal Stem Cells from Human Alveolar Periosteum and Effects of Vitamin D on Osteogenic Activity of Periosteum-derived Cells
06:47

Isolation of Mesenchymal Stem Cells from Human Alveolar Periosteum and Effects of Vitamin D on Osteogenic Activity of Periosteum-derived Cells

Published on: May 4, 2018

9.3K
Stimulation of Notch Signaling in Mouse Osteoclast Precursors
08:01

Stimulation of Notch Signaling in Mouse Osteoclast Precursors

Published on: February 28, 2017

7.8K

Related Experiment Videos

Last Updated: Jun 13, 2025

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
08:42

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

4.4K
Isolation of Mesenchymal Stem Cells from Human Alveolar Periosteum and Effects of Vitamin D on Osteogenic Activity of Periosteum-derived Cells
06:47

Isolation of Mesenchymal Stem Cells from Human Alveolar Periosteum and Effects of Vitamin D on Osteogenic Activity of Periosteum-derived Cells

Published on: May 4, 2018

9.3K
Stimulation of Notch Signaling in Mouse Osteoclast Precursors
08:01

Stimulation of Notch Signaling in Mouse Osteoclast Precursors

Published on: February 28, 2017

7.8K

Area of Science:

  • Cell Biology
  • Genetics
  • Biochemistry

Background:

  • Plastin-3 (PLS3) is an actin-bundling protein crucial for cellular processes.
  • Genetic defects in PLS3 lead to X-linked osteoporosis and childhood fractures.
  • The precise molecular mechanisms underlying PLS3-related bone disorders are not fully understood.

Purpose of the Study:

  • To investigate the functional compensation of Plastin-3 (PLS3) by other actin-bundling proteins.
  • To explore the molecular etiology of PLS3-related bone pathologies.
  • To identify global gene expression changes and affected pathways following PLS3 knockdown.

Main Methods:

  • Morpholino-mediated knockdown of *pls3* in zebrafish.
  • Analysis of primary dermal fibroblasts from patients with *PLS3* variants during osteogenic differentiation.
  • RNA sequencing (RNA-seq) of murine MLO-Y4 cells following *Pls3* knockdown.

Main Results:

  • ACTN1 and ACTN4 partially rescued skeletal deformities in zebrafish lacking PLS3, while FSCN1 did not.
  • Fibroblasts from patients with *PLS3* variants exhibited normal osteogenic differentiation.
  • PLS3 knockdown in MLO-Y4 cells altered expression of genes involved in Wnt and Th17 cell differentiation pathways, with increased WNT2 in patient cells.

Conclusions:

  • Functional compensation by actin-bundling proteins is insufficient to fully rescue PLS3-deficiency phenotypes.
  • PLS3-related bone pathology involves broader molecular pathways beyond actin-bundling.
  • The findings implicate altered Wnt signaling and Th17 cell differentiation in the pathogenesis of PLS3-related bone disorders.